Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion type Assertion NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_head.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion description "[We analyzed the influence of angiotensin-converting enzyme (ACE) I/D, angiotensinogen (AGT) M235T and angiotensin-II-type-1 receptor (AT1R) A1166C genetic polymorphisms on the clinical course of focal segmental glomerulosclerosis (FSGS).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion evidence source_evidence_literature NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion SIO_000772 14610337 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion wasDerivedFrom befree-20140225 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.
- NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_assertion wasGeneratedBy ECO_0000203 NP171017.RARPLfIUXGWex7Kf9Y-d6MmO8bPQT16myrzT8sE46jgkc130_provenance.